If you are a member of the press, please contact:
Stef MendellHead, Global CommunicationsVoice: +1.919.483.2839stefanie.x.mendell@stiefel.comZach RandlesDirector, Global Digital CommunicationsVoice: +1.919.483.2839Zachary.e.randles@stiefel.comRobin GaitensDirector, Stiefel Product CommunicationsVoice: +1.919.483.2839robin.c.gaitens@gsk.comAdd Erin SingerDirector, Stiefel External CommunicationsVoice: +1.919.483.2839erin.b.singer@stiefel.com
Oct 12 2010 Stiefel, a GSK company, Receives FDA Approval of SORILUX™ (calcipotriene) Foam, 0.005%
Aug 31 2010 MaxClarity Officially Kicks Off the Fresh Face Challenge
Jul 27 2010 Stiefel, a GSK company, Brings Acne Innovation Directly to Consumers with MaxClarity™
Jul 16 2010 Stiefel, a GSK company, Receives FDA Approval of VELTIN™ (clindamycin phosphate and tretinoin) Gel 1.2%/0.025%
<Previous 1 2 3 Next>
